VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,452,257 | -74.6% | 154,990 | -33.6% | 0.00% | -100.0% |
Q2 2023 | $5,728,221 | +94.8% | 233,519 | +84.8% | 0.00% | – |
Q1 2023 | $2,941,000 | +77560.4% | 126,355 | -15.5% | 0.00% | – |
Q4 2022 | $3,787 | -99.8% | 149,619 | +78.9% | 0.00% | – |
Q3 2022 | $1,613,000 | -23.6% | 83,635 | +0.8% | 0.00% | – |
Q2 2022 | $2,112,000 | +2.7% | 82,956 | +3.7% | 0.00% | – |
Q1 2022 | $2,057,000 | -73.0% | 79,973 | -56.0% | 0.00% | -100.0% |
Q4 2021 | $7,613,000 | -4.2% | 181,822 | -0.4% | 0.00% | 0.0% |
Q3 2021 | $7,946,000 | -20.1% | 182,576 | -13.2% | 0.00% | 0.0% |
Q2 2021 | $9,939,000 | -7.7% | 210,228 | +0.0% | 0.00% | 0.0% |
Q1 2021 | $10,773,000 | +176.9% | 210,139 | +44.6% | 0.00% | 0.0% |
Q4 2020 | $3,891,000 | -12.2% | 145,298 | +23.6% | 0.00% | 0.0% |
Q3 2020 | $4,434,000 | -10.9% | 117,523 | -3.3% | 0.00% | 0.0% |
Q2 2020 | $4,978,000 | +19.4% | 121,531 | -0.1% | 0.00% | 0.0% |
Q1 2020 | $4,169,000 | +232.2% | 121,655 | +22.0% | 0.00% | – |
Q4 2019 | $1,255,000 | – | 99,741 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |